Squarepoint’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5M Sell
187,400
-148,800
-44% -$21.2M 0.02% 695
2025
Q4
$55.9M Buy
336,200
+137,100
+69% +$22.9M 0.06% 369
2025
Q3
$39M Sell
199,100
-48,500
-20% -$7.98M 0.04% 488
2025
Q2
$22.4M Buy
247,600
+114,000
+85% +$9.01M 0.02% 714
2025
Q1
$7.97M Buy
133,600
+100,200
+300% +$9.27M 0.01% 1134
2024
Q4
$4.42M Buy
33,400
+13,300
+66% +$1.25M ﹤0.01% 1742
2024
Q3
$1.05M Hold
20,100
﹤0.01% 2569
2024
Q2
$1.22M Buy
+20,100
New +$1.39M ﹤0.01% 2414

Other funds holding ALAB

Squarepoint's ALAB Position: Q1 2026 in Review

Squarepoint reduced its Astera Labs (ALAB) stake by 31% in Q1 2026, selling an estimated $9.27M and leaving 141,557 shares worth $15.5M. The position accounts for 0.02% of the portfolio, ranked #831.

Squarepoint first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $42.3M in Q2 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Squarepoint held 141,557 shares of Astera Labs worth $15.5M as of Q1 2026.
  • Squarepoint sold 65,074 Astera Labs shares in Q1 2026, an estimated $9.27M.
  • Astera Labs made up 0.02% of Squarepoint's portfolio in Q1 2026, its #831 holding.
  • Squarepoint first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
  • Squarepoint's Astera Labs position peaked at $42.3M in Q2 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.